Lilly expecting Q2 IPR&D pre-tax charge of around $0.14 per share: report (NYSE:LLY)

Eli Lilly (NYSE:LLY) said Friday it expects to report Q2 IPR&D pre-tax charges of around $154M, amounting to approximately $0.14 a share on a GAAP and non-GAAP basis, according to Bloomberg.
Analysts were expecting Lilly to report Q2 GAAP EPS of $2.76 and non-GAAP EPS of $2.81.
The drugmaker is expected to release its earnings report on Aug. 8.